Successful treatment of refractory duodenal Crohn's disease with infliximab.
Odashima
Masaru
M
Department of Gastroenterology, Akita University of Medicine, 1-1-1, Hondo, Akita city, Akita 010-8543, Japan. odashima@doc.med.akita-u.ac.jp
Otaka
Michiro
M
Jin
Mario
M
Horikawa
Youhei
Y
Matsuhashi
Tamostu
T
Ohba
Reina
R
Koizumi
Shigeto
S
Kinoshita
Nobukatsu
N
Takahashi
Taiji
T
Watanabe
Sumio
S
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003092:Colitis / Q000188:drug therapy*; D003251:Constriction, Pathologic; D003424:Crohn Disease / Q000188:drug therapy*; D004386:Duodenum / Q000473:pathology*; D016099:Endoscopy, Gastrointestinal; D006801:Humans; D000069285:Infliximab; D008297:Male
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab